Literature DB >> 30948200

Critical Care of Patients After Pulmonary Thromboendarterectomy.

Wolf B Kratzert1, Eva K Boyd2, Rajan Saggar3, Richard Channick3.   

Abstract

Pulmonary thromboendarterectomy (PTE) remains the only curative surgery for patients with chronic thromboembolic pulmonary hypertension (CTEPH). Postoperative intensive care unit care challenges providers with unique disease physiology, operative sequelae, and the potential for detrimental complications. Central concerns in patients with CTEPH immediately after PTE relate to neurologic, pulmonary, hemodynamic, and hematologic aspects. Institutional experience in critical care for the CTEPH population, a multidisciplinary team approach, patient risk assessment, and integration of current concepts in critical care determine outcomes after PTE surgery. In this review, the authors will focus on specific aspects unique to this population, with integration of current available evidence and future directions. The goal of this review is to provide the cardiac anesthesiologist and intensivist with a comprehensive understanding of postoperative physiology, potential complications, and contemporary intensive care unit management immediately after pulmonary endarterectomy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic thromboembolic pulmonary hypertension; critical care; critically ill; pulmonary endarterectomy; pulmonary hypertension; pulmonary thromboendarterectomy

Year:  2019        PMID: 30948200     DOI: 10.1053/j.jvca.2019.03.005

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  2 in total

1.  Case Report: Successful Concomitant Pulmonary Thromboendarterectomy and Carotid Endarterectomy.

Authors:  Zhan Liu; Xiaopeng Liu; Xia Zheng; Fan Lin; Guang Sun; Zhidong Ye; Yanan Zhen; Peng Liu
Journal:  Front Cardiovasc Med       Date:  2022-05-25

2.  Brazilian Thoracic Society recommendations for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension.

Authors:  Caio Julio Cesar Dos Santos Fernandes; Jaquelina Sonoe Ota-Arakaki; Frederico Thadeu Assis Figueiredo Campos; Ricardo de Amorim Correa; Marcelo Basso Gazzana; Carlos Vianna Poyares Jardim; Fábio Biscegli Jatene; Jose Leonidas Alves Junior; Roberta Pulcheri Ramos; Daniela Tannus; Carlos Teles; Mario Terra Filho; Daniel Waetge; Rogerio Souza
Journal:  J Bras Pneumol       Date:  2022-06-24       Impact factor: 2.800

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.